Import dependency
Long international lead times and limited alternatives can turn a recurring item into a service exposure.
Supply Assurance for MedTech & Life Sciences
ZERTELA is developing a specialized Supply Assurance model for selected materials and consumables used by MedTech and Life Sciences manufacturers in Costa Rica. It is designed to combine reliable sourcing, local availability where justified, quality and documentation support, and responsive replenishment.
For OEMs · Contract manufacturers · Tier suppliers · Selected Life Sciences operations
Under development · Industry discovery underway in Costa Rica

Where supply friction appears
Unit price matters—but so do lead time, qualification effort, working capital and shortage risk.
Long international lead times and limited alternatives can turn a recurring item into a service exposure.
Specifications, samples and stakeholder approvals can make switching sources slow and resource-intensive.
Missing or disconnected technical and quality information can delay evaluation and purchasing decisions.
Rigid order cycles can create avoidable expediting, excess stock or recurring shortage risk.
The ZERTELA model
The model is designed around selected requirements—not catalog breadth—and combines only the capabilities that validated customer demand supports.
Assess potential manufacturers and supply routes against technical fit, consistency, capacity and true landed cost.
Design local stock or buffer concepts only where service requirements, validated demand and commercial viability justify them.
Coordinate specifications, samples, traceability and required supplier information to support customer-led evaluation.
Explore scheduled replenishment, blanket orders, safety stock and VMI models around actual consumption and validated economics.
A structured path
The proposed path connects commercial sourcing decisions with the technical and operational gates expected in regulated manufacturing environments.
Clarify the material, specification, use case, demand pattern, current supply path and service exposure.
Screen potential manufacturers and supply routes for technical, quality, capacity and commercial fit.
Coordinate samples, documentation and review gates for evaluation led by the customer’s authorized teams.
Define a realistic sourcing, availability and replenishment model around the validated requirement.
ZERTELA supports the evaluation process. Final product and supplier approval remain with the customer’s authorized functions.
Institutional overview
A concise overview of how ZERTELA approaches supply continuity for MedTech & Life Sciences.

Current discovery scope
Our initial discovery scope includes recurring imported categories where continuity, documentation and responsiveness may create meaningful value. Customer evidence will determine where ZERTELA builds its initial portfolio.
Why ZERTELA
ZERTELA is being built on more than 20 years of senior global and Latin American supply-chain experience across planning, sourcing, inventory and operations.
Direct senior involvement in shaping the model, customer discovery and opportunity assessment.
A focused study of Costa Rica’s MedTech and Life Sciences ecosystem—not an opportunistic import model.
A model intended to connect sourcing, quality discipline, availability and replenishment around selected requirements.

A 30-minute industry discovery conversation
Share one recurring material, component or supply path that creates operational exposure. We will use the conversation to understand the current route, qualification requirements, demand pattern and what a new supplier would need to demonstrate.